Next |
home / stock / cur / cur message board
Subject | By | Source | When |
---|---|---|---|
$SNCA~could be crazy huge,got @1.65 pps | ALERTS100%to10000%GAIN | investorshub | 04/26/2021 1:36:03 PM |
Yes merger in play here loading up $$$$ | INFINITI | investorshub | 04/05/2021 12:52:06 PM |
$SNCA is screaming for the top as investors | AlphaStockNews | investorshub | 04/05/2021 10:55:59 AM |
Whos the idiots that are selling this low | INFINITI | investorshub | 03/31/2021 11:42:44 PM |
Filing of Certain Prospectuses and Communications in Connection | INFINITI | investorshub | 03/30/2021 11:09:04 AM |
On December 17, 2020, the Company announced the | INFINITI | investorshub | 03/25/2021 3:47:32 PM |
Clays video was great bulls are in full control | INFINITI | investorshub | 03/22/2021 9:24:56 PM |
* * $SNCA Video Chart 03-22-2021 * * | ClayTrader | investorshub | 03/22/2021 8:53:49 PM |
Squeeze $$$$ | INFINITI | investorshub | 03/22/2021 2:47:45 PM |
Merger talks $$$$ | INFINITI | investorshub | 03/22/2021 1:18:51 PM |
Looks good got in $$$$ | INFINITI | investorshub | 03/22/2021 1:17:36 PM |
$SNCA is headed for the top in the | AlphaStockNews | investorshub | 03/22/2021 12:35:11 PM |
what happened to Phase III ALS trial??? Eva Feldman? | nealhugh | investorshub | 03/20/2021 8:59:04 PM |
This company is finished. | Pedro2004 | investorshub | 03/18/2021 12:56:34 PM |
Don't get sucked into the scam. | Pedro2004 | investorshub | 03/18/2021 12:56:19 PM |
$SNCA is screaming for the top in the | AlphaStockNews | investorshub | 03/18/2021 12:29:19 PM |
We are back inside the bollinger bands with | redcoyote | investorshub | 01/15/2021 1:38:36 PM |
I picked up some of this yesterday. I | redcoyote | investorshub | 01/14/2021 2:41:17 PM |
News Leading BioSciences Announces FDA Fast Track Designation Granted | TraderInvictus | investorshub | 01/13/2021 1:46:05 PM |
Whats the scoop here. My buddy introduced me yesterday. | MacBoys | investorshub | 12/18/2020 3:11:25 PM |
News, Short Squeeze, Breakout and More Instantly...
RADNOR, Pa., March 19, 2021 (GLOBE NEWSWIRE) -- NeuroRx, Inc. announced the first patient in its P2/3 study of inhaled ZYESAMI™ in the treatment of moderate and severe COVID-19 (AVICOVID-2) was dosed at the University of California Irvine. The trial will be conducted at 10-15 clinica...
GERMANTOWN, Md. , Sept. 2, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today provided the following letter from Dr. Ken Carter , the Company's Executive Chairm...
GERMANTOWN, Md. , May 27, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq:SNCA), a clinical-stage biopharmaceutical company developing novel treatments for various diseases of high unmet medical need, today announced the closing of its previously announced $5 million registered...